As of Monday, December 29, Aligos Therapeutics, Inc.’s ALGS share price has dipped by 5.24%, which has investors questioning ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...

This move represented a sharp increase in price on volume nearly 3x the average daily trading volume, indicating robust ...

“Photon Design's next-generation, EPIPPROP simulator, will offer the flexibility to split waveguides, simulating this process ...

An announcement from Shionogi & Co ( ($JP:4507) ) is now available. Shionogi has received Japanese regulatory approval to manufacture and market ...

Athira Pharma has joined an attempt to rescue an asset abandoned by Pfizer. The biotech has secured near-global rights to a phase 3 breast cancer prospect in a deal with Sermonix Pharmaceuticals.

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified ...

Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, ...

Abstract: This article presents a discrete-time secondorder ΔΣ modulator for the audio applications. In this modulator, a novel dynamic amplifier is proposed to realize the switched-capacitor (SC) ...

This is my version of a C64 RF Modulator replacement based on the schematics of similar designs like Zero-X/OMS's Modified Commodore RF Modulator Design and JMP$FCE2 ...